Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar;10(1):75-81.
doi: 10.3969/j.issn.1671-5411.2013.01.012.

Ageing and Brugada Syndrome: Considerations and Recommendations

Affiliations
Free PMC article

Ageing and Brugada Syndrome: Considerations and Recommendations

Pieter G Postema et al. J Geriatr Cardiol. .
Free PMC article

Abstract

Brugada syndrome is an inherited disease associated with an increased risk of lethal ventricular arrhythmias. Such arrhythmias stem from innate disruptions in cardiac electrophysiology. Typically, such arrhythmias occur in the third or fourth decade of life. However, Brugada syndrome may also affect geriatric patients. In this paper, we focus on the ageing patient with Brugada syndrome, and specifically, on the interaction between Brugada syndrome and the more usually acquired clinical problems that may occur with increasing age, such as the use of cardiovascular and non-cardiovascular drugs, or the need for surgery. Such common conditions may also disrupt cardiac electrophysiology, thereby conferring added risk for Brugada syndrome patients. We present some considerations and recommendations that may serve as guidance to address these complexities.

Keywords: Aging; Arrhythmias; Brugada syndrome; Geriatrics; Risk stratification; Sudden death.

Figures

Figure 1.
Figure 1.. Example of the development of a type-1 Brugada ECG during an ajmaline provocation test.
Please note the absence of abnormal STT segments at baseline and the development of typical type-1, coved type, STT segments in the right precordial leads in concert with clear conduction delay upon ajmaline provocation. Please also note that the V3 lead is placed one intercostal space above V1 (V1 ic3) and V5 is placed one intercostal space above V2 (V2 ic3) to increase sensitivity.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multi-center report. J AmCollCardiol. 1992;20:1391–1396. - PubMed
    1. Wilde AA, Antzelevitch C, Borggrefe M, et al. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation. 2002;106:2514–2519. - PubMed
    1. Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation. 2000;101:510–515. - PubMed
    1. Postema PG, Wolpert C, Amin AS, et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website ( www.brugadadrugs.org). Heart Rhythm. 2009;6:1335–1341. - PMC - PubMed
    1. Wilde AA, Postema PG, Di Diego JM, et al. The pathophysiological mechanism underlying Brugada syndrome. Depolarization versus repolarization. J Mol Cell Cardiol. 2010;49:543–553. - PMC - PubMed

LinkOut - more resources

Feedback